topic-04016024 News Coverage on Leveraged Buyouts - CTNow
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Leveraged Buyouts

A collection of news and information related to Leveraged Buyouts published by this site and its partners.

Top Leveraged Buyouts Articles

Displaying items 12-22
  • Ackman turns up heat on Allergan, calls for shareholder meeting

    The jockeying for control of Botox maker Allergan Inc. is getting nastier. Activist investor Bill Ackman called Monday for a special meeting at which Allergan shareholders could potentially vote out the bulk of the Irvine company's board of directors....
  • Bid for Allergan turns hostile as Ackman calls for shareholder meeting

    The jockeying for control of Botox maker Allergan Inc. is getting downright hostile — and even more bizarre. Activist investor Bill Ackman called for a special meeting at which Allergan shareholders could potentially vote out the bulk of the...
  • Allergan co-founder speaks out against Valeant takeover

    The board and chief executive of Irvine takeover target Allergan Inc. heard a voice from the past Tuesday at the company's annual meeting of shareholders. Gavin S. Herbert, Allergan's co-founder and former chairman, urged the company's directors to...
  • Botox-maker Allergan rejects takeover bid from Valeant

    Botox-maker Allergan Inc. said it rejected a takeover bid from Valeant Pharmaceuticals International Inc., a deal the company said undervalued its worth and posed significant risks to shareholders. Last month, the Irvine drugmaker received an...
  • Allergan urges shareholders to reject Valeant offer

    Allergan urges shareholders to reject Valeant offer
    Allergan Inc., the Irvine company that makes Botox, is urging shareholders to reject a buyout offer from a Canadian pharmaceutical firm. Valeant Pharmaceuticals International Inc. has offered to buy all of Allergan’s shares for a combination of...
  • Allergan urges shareholders to reject Valeant buyout offer

    Allergan urges shareholders to reject Valeant buyout offer
    Allergan Inc., the Irvine company that makes Botox, is urging shareholders to reject a buyout offer from a Canadian pharmaceutical firm. Valeant Pharmaceuticals International Inc. said last week that it will take its acquisition offer directly to...
  • Speculation builds over sale of American Apparel

    Speculation builds over sale of American Apparel
    Is American Apparel Inc. up for sale? The Los Angeles company's abrupt ouster this week of Chief Executive Dov Charney has sparked intense speculation that it is now a prime takeover target. But those rumors were vehemently dismissed Friday by its...
  • Lisle-based GreatBanc Trust pays $5.25 million to settle lawsuit

    Lisle-based GreatBanc Trust pays $5.25 million to settle lawsuit
    Lisle-based GreatBanc Trust Co. has agreed to pay $5.25 million to settle a lawsuit brought by the U.S. Labor Department that alleged the company violated its fiduciary duty as trustee of a employee stock ownership plan (ESOP). The Labor Department...
  • Activision Blizzard CEO must face lawsuit over $8.2-billion buyout

    Activision Blizzard CEO must face lawsuit over $8.2-billion buyout
    Activision Blizzard Inc. failed to persuade a judge to toss out a lawsuit that claims the company's board improperly let its chief executive take part in a group that bought a large chunk of the Santa Monica-based video game company. On Thursday, a...
  • A closer look at Mitt Romney's job creation record

    A closer look at Mitt Romney's job creation record
      Shortly after Mitt Romney resigned from Bain Capital in 1999 to run the Olympics in Salt Lake City, potential investors received a prospectus touting the extraordinary profits earned by the private equity firm that Romney controlled for 15 years....
  • Exelon boss wants merger badly, and he's paying for it

    John Rowe made no secret of the fact that he badly wanted a signature merger to top off his career as the chief executive of Exelon Corp. How badly can be seen in the settlement he just agreed to in Exelon's bid to purchase Baltimore's Constellation...